170 related articles for article (PubMed ID: 15128428)
21. Recombinant factor VIIa in the treatment of bleeding.
Midathada MV; Mehta P; Waner M; Fink LM
Am J Clin Pathol; 2004 Jan; 121(1):124-37. PubMed ID: 14750250
[TBL] [Abstract][Full Text] [Related]
22. Recombinant activated factor seven in acute life-threatening bleeding in neonates: report on three cases and review of literature.
Hünseler C; Kribs A; Eifinger F; Roth B
J Perinatol; 2006 Nov; 26(11):706-13. PubMed ID: 17066067
[TBL] [Abstract][Full Text] [Related]
23. Is recombinant FVIIa the magic bullet in the treatment of major bleeding?
Spahn DR; Tucci MA; Makris M
Br J Anaesth; 2005 May; 94(5):553-5. PubMed ID: 15814804
[No Abstract] [Full Text] [Related]
24. [Activated recombinant factor VII (Novoseven) in multiple trauma patients: an outcome analysis].
Grinţescu I; Tulbure D; Mirea L
Chirurgia (Bucur); 2006; 101(6):615-24. PubMed ID: 17283837
[TBL] [Abstract][Full Text] [Related]
25. Treatment of an acquired coagulopathy with recombinant activated factor VII in a damage-control patient.
Holcomb JB; Hoots K; Moore FA
Mil Med; 2005 Apr; 170(4):287-90. PubMed ID: 15916295
[TBL] [Abstract][Full Text] [Related]
26. "Off-license" use of recombinant activated factor VII.
Ghorashian S; Hunt BJ
Blood Rev; 2004 Dec; 18(4):245-59. PubMed ID: 15501553
[TBL] [Abstract][Full Text] [Related]
27. More on: Platelet count and the use of recombinant factor VIIa for the treatment of bleeding complications after hematopoietic stem cell transplantation.
Marietta M; Facchini L; Girardis M; Luppi M; Torelli G
J Thromb Haemost; 2006 Jan; 4(1):288. PubMed ID: 16409495
[No Abstract] [Full Text] [Related]
28. Successful treatment of life-threatening bleeding after cesarean section with recombinant activated factor VII.
Heilmann L; Wild C; Hojnacki B; Pollow K
Clin Appl Thromb Hemost; 2006 Apr; 12(2):227-9. PubMed ID: 16708127
[TBL] [Abstract][Full Text] [Related]
29. A response to 'the use of recombinant activated factor VII in the control of haemorrhage following blunt pelvic trauma.
Geoghegan J; Tasker L
Anaesthesia; 2005 Nov; 60(11):1156-7; author reply 1157. PubMed ID: 16229713
[No Abstract] [Full Text] [Related]
30. Effective treatment of severe bleeding due to acquired thrombocytopathia by single dose administration of activated recombinant factor VII.
Meijer K; Sieders E; Slooff MJ; de Wolf JT; van der Meer J
Thromb Haemost; 1998 Jul; 80(1):204-5. PubMed ID: 9684815
[No Abstract] [Full Text] [Related]
31. Antidotes to haemorrhage: recombinant factor VIIa.
Kessler CM
Best Pract Res Clin Haematol; 2004 Mar; 17(1):183-97. PubMed ID: 15171966
[TBL] [Abstract][Full Text] [Related]
32. Management of thrombocytopenic bleeding: is there a role for recombinant coagulation factor VIIa?
Poon MC
Curr Hematol Rep; 2003 Mar; 2(2):139-47. PubMed ID: 12901145
[TBL] [Abstract][Full Text] [Related]
33. Pro/con debate: does recombinant factor VIIa have a role to play in the treatment of patients with acute nontraumatic hemorrhage?
Pieri P; Stein DM; Scarpelini S; Rizoli S
Crit Care; 2006; 10(3):214. PubMed ID: 16762042
[TBL] [Abstract][Full Text] [Related]
34. [Recombinant activated factor VII in uncontrolled hemorrhage].
Colomina MJ; Altisent C; Guerrero E; Godet C
Med Clin (Barc); 2005 Feb; 124(4):156. PubMed ID: 15713248
[No Abstract] [Full Text] [Related]
35. The use of recombinant activated factor VII in platelet-associated bleeding.
Franchini M; Lippi G; Guidi GC
Hematology; 2008 Feb; 13(1):41-5. PubMed ID: 18534065
[TBL] [Abstract][Full Text] [Related]
36. Treatment of critical bleeding in the future intensive care unit.
Goodnough LT
Intensive Care Med; 2002 Oct; 28 Suppl 2():S221. PubMed ID: 12583409
[No Abstract] [Full Text] [Related]
37. Life-threatening hemorrhage in neonates: management with recombinant activated factor VII.
Veldman A; Fischer D; Voigt B; Beyer PA; Schlösser R; Allendorf A; Kreuz W
Intensive Care Med; 2002 Nov; 28(11):1635-7. PubMed ID: 12415453
[TBL] [Abstract][Full Text] [Related]
38. Treatment of acquired factor VIII inhibitor with recombinant activated factor VIIa: data from the Italian registry of acquired hemophilia.
Baudo F; de Cataldo F; Gaidano G;
Haematologica; 2004 Jun; 89(6):759-61. PubMed ID: 15194550
[TBL] [Abstract][Full Text] [Related]
39. Recombinant activated factor VII: panacea or passing fad?
Parker RI
Pediatr Crit Care Med; 2005 May; 6(3):379-80. PubMed ID: 15880015
[No Abstract] [Full Text] [Related]
40. Efficacy and safety of recombinant factor VIIa in the treatment of bleeding episodes in patients with aplastic anemia.
Al Hammadi AM; Sallah S
J Thromb Haemost; 2007 Feb; 5(2):435-6. PubMed ID: 17269940
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
